Coeptis Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell COEP and other ETFs, options, and stocks.

About COEP

Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company, which engages in developing innovative cell therapy platforms for cancer that can disrupt conventional treatment paradigms and improve patient outcomes. It operates through the Biotechnology and Technology segments.

CEO

David Mehalick

CEODavid Mehalick

Employees

Employees7

Headquarters

Wexford, Pennsylvania

HeadquartersWexford, Pennsylvania

Founded

2017

Founded2017

Employees

Employees7

COEP Key Statistics

Market cap

31.79M

Market cap31.79M

Price-Earnings ratio

-1.65

Price-Earnings ratio-1.65

Dividend yield

—

Dividend yield—

Average volume

38.68K

Average volume38.68K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$13.70

52 Week high$13.70

52 Week low

$2.31

52 Week low$2.31

People also own

Based on the portfolios of people who own COEP. This list is generated using Robinhood data, and it’s not a recommendation.

Mullen Automotive

Tonix Pharmaceuticals